sodium phosphate, dibasic, heptahydrate; sodium phosphate, monobasic, monohydrate · Hospira · NDA 018892
Sodium Phosphates In Plastic Container
Earliest generic entry, as listed
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- Generic approved · ANDA 220683, Caplin · 018892-001Approved 23 Feb 2026Detected 25 Oct 2026Historical import
- Generic approved · ANDA 218274, Amneal · 018892-001Approved 15 Oct 2026Detected 25 Oct 2026Historical import
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 018892 · 001 · RLD | solution, intravenous | 4.02GM/15ML;4.14GM/15ML (268MG/ML;276MG/ML) | open |